Nexgel Inc
NXGLW0.178USD
-0.057-24.46%
Close （ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of Nexgel Inc Company
NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CG labs segment comprises the CG Converting and Packaging, LLC used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its hydrogel consumer products are marketed under the brand names MedaGel and LumaGel Beauty. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Dermablock. It also specializes in eye and eyelash consumer products.
Nexgel Inc Info
Ticker SymbolNXGLW
Company nameNexgel Inc
IPO dateDec 22, 2021
CEOMr. Adam Levy
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
Address2150 Cabot Blvd West,
CityLANGHORNE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code19047
Phone12157028550
Websitehttps://nexgel.com/
Ticker SymbolNXGLW
IPO dateDec 22, 2021
CEOMr. Adam Levy
Company Executives of Nexgel Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Steven Ciardiello
Mr. Steven Ciardiello
Director
Director
--
--
Mr. Steven Mark Glassman
Mr. Steven Mark Glassman
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Scott R. Henry
Mr. Scott R. Henry
Independent Director
Independent Director
--
--
Mr. Nachum Stein
Mr. Nachum Stein
Independent Director
Independent Director
--
--
Dr. Jerome B. Zeldis, M.D., Ph.D.
Dr. Jerome B. Zeldis, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Mr. Adam Levy
Mr. Adam Levy
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Joseph F. (Joe) McGuire
Mr. Joseph F. (Joe) McGuire
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Steven Ciardiello
Mr. Steven Ciardiello
Director
Director
--
--
Mr. Steven Mark Glassman
Mr. Steven Mark Glassman
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Scott R. Henry
Mr. Scott R. Henry
Independent Director
Independent Director
--
--
Mr. Nachum Stein
Mr. Nachum Stein
Independent Director
Independent Director
--
--
Dr. Jerome B. Zeldis, M.D., Ph.D.
Dr. Jerome B. Zeldis, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
7
818.73K
0.00%
-193.12K
2025Q3
6
769.01K
0.00%
-247.83K
2025Q2
7
814.60K
0.00%
-267.50K
2025Q1
8
814.60K
0.00%
-281.60K
2024Q4
7
807.10K
0.00%
-83.18K
2024Q3
7
826.11K
0.00%
-76.17K
2024Q2
8
918.18K
0.00%
-74.03K
2024Q1
8
918.11K
0.00%
-76.58K
2023Q4
8
918.21K
0.00%
-76.78K
2023Q3
8
928.51K
0.00%
-66.58K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Armistice Capital LLC
550.00K
0%
--
--
Sep 30, 2025
Warberg Asset Management LLC
166.86K
0%
-17.64K
-9.56%
Sep 30, 2025
Clear Street LLC
50.81K
0%
-100.00
-0.20%
Jun 30, 2025
Altium Capital Management LP
--
0%
-225.00K
-100.00%
Dec 31, 2024
UBS Financial Services, Inc.
339.00
0%
-1.00K
-74.68%
Sep 30, 2025
Clear Street Group Inc
50.71K
0%
+50.71K
--
Sep 30, 2025
BofA Global Research (US)
--
0%
-100.00
-100.00%
Jun 30, 2025
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Nexgel Inc?
The top five shareholders of Nexgel Inc are:
Armistice Capital LLC holds 550.00K shares, accounting for 0.00% of the total shares.
Warberg Asset Management LLC holds 166.86K shares, accounting for 0.00% of the total shares.
Clear Street LLC holds 50.81K shares, accounting for 0.00% of the total shares.
Altium Capital Management LP holds 0.00 shares, accounting for 0.00% of the total shares.
UBS Financial Services, Inc. holds 339.00 shares, accounting for 0.00% of the total shares.
Armistice Capital LLC holds 550.00K shares, accounting for 0.00% of the total shares.
Warberg Asset Management LLC holds 166.86K shares, accounting for 0.00% of the total shares.
Clear Street LLC holds 50.81K shares, accounting for 0.00% of the total shares.
Altium Capital Management LP holds 0.00 shares, accounting for 0.00% of the total shares.
UBS Financial Services, Inc. holds 339.00 shares, accounting for 0.00% of the total shares.
What are the top three shareholder types of Nexgel Inc?
The top three shareholder types of Nexgel Inc are:
Other
Other
How many institutions hold shares of Nexgel Inc (NXGLW)?
As of 2025Q4, 7 institutions hold shares of Nexgel Inc, with a combined market value of approximately 818.73K, accounting for --% of the total shares. Compared to 2025Q3, institutional shareholding has increased by --.
What is the biggest source of revenue for Nexgel Inc?
In --, the -- business generated the highest revenue for Nexgel Inc, amounting to -- and accounting for --% of total revenue.
